–
Teva sold the sleeping pills in packaging for heart failure medication.
–
Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Photo: For Illustration only
–
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has recalled sleeping pills which were mistakenly sold in packaging for a heart failure medication, the French media reports.
The company recalled the two products at the order of France’s National Agency for the Safety of Medicines and Health Products (MSNA). The case involves Zopiclone, which was mistakenly sold in packaging for Furosemide. Teva says that the error was discovered by a pharmacist, after a patient who took the medication suffered from unusual sleepiness. A test found that the incident involved two problematic packages, which the company recalled.Teva called on patients taking Furosemide to stop taking the medication supplied and return it to the pharmacist in order to receive the correct one.
